Skip to main content

Table 2 Patient characteristics

From: MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index

  IDRC LLMPP R-CHOP AAU
n 468 233 73
Gender
 Female 198 (42%) 99 (42%) 30 (41%)
 Male 270 (58%) 134 (58%) 43 (59%)
Age
 Median 63 61 66
 Range 18–92 17–92 20–87
IPI
 0–1 254 (54%) 94 (40%) 48 (66%)
 2–5 168 (36%) 70 (30%) 21 (29%)
 NA 46 (10%) 69 (30%) 4 (5%)
ABC / GCB
 ABC 199 (43%) 93 (40%) 32 (44%)
 GCB 225 (48%) 107 (46%) 32 (44%)
 UC 44 (9%) 33 (14%) 9 (12%)
  1. Number of patients and percentage within cohort / variable. ABC activated B-cell-like, GCB germinal center B-cell-like, IPI International prognostic index, NA not available, n number of patients, UC unclassified